MarketPeel
NC

Neil Harris Cohen

CMMB
DIRECTOR · CHEMOMAB THERAPEUTICS LTD. · CIK 0001840006
FILING MIX · LIFETIME96%/4%
BUYS
22
SELLS
1
TOTAL VALUE
$152.2K
COMPANIES
1
ACTIVE SINCE
Mar 2021
HOLDINGS NOW
6,875
AVG SELL PX
$2.00
TRADE KIND
SHOWING 23 / 23
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
8 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Neil Harris Cohen, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d8+62.50%-5.74%+2.87%-8.61%-1.30%
14d8+62.50%-10.26%+4.53%-14.79%-6.78%
30d8+62.50%-14.43%+3.04%-17.46%-6.13%
60d8+25.00%-35.18%-0.21%-34.97%-26.36%
90d8+25.00%-28.42%-0.89%-27.53%-9.81%
180d8+12.50%-39.55%+2.36%-41.91%-33.93%
1y8+12.50%-70.10%+2.62%-72.73%-59.35%
2y8+12.50%-78.28%+22.89%-101.17%-103.96%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
CMMB · 6,875 shares · as of Mar 16, 2023
03,1026,2059,30712,40920222023SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
2021
2021
2021
2022
2022
2022
2022
2023
FLOW · 22 buys / 1 sellsCOVERAGE · 9 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
CMMB
CHEMOMAB THERAPEUTICS LTD.
PURCHASEGRANT
Stock grant
6,8756,875Mar 16, 2023Mar 23, 2023View →
CMMB
CHEMOMAB THERAPEUTICS LTD.
SALE
2,409$2.00$4.8K10,000Nov 16, 2022Nov 18, 2022View →
CMMB
CHEMOMAB THERAPEUTICS LTD.
PURCHASE
2,000$3.19$6.4K12,409May 18, 2022May 19, 2022View →
CMMB
CHEMOMAB THERAPEUTICS LTD.
PURCHASE
2,000$4.56$9.1K10,409Mar 14, 2022Mar 15, 2022View →
CMMB
CHEMOMAB THERAPEUTICS LTD.
PURCHASE
2,000$4.30$8.6K8,409Mar 14, 2022Mar 15, 2022View →
CMMB
CHEMOMAB THERAPEUTICS LTD.
PURCHASE
2,000$4.20$8.4K6,409Mar 14, 2022Mar 15, 2022View →
CMMB
CHEMOMAB THERAPEUTICS LTD.
PURCHASEGRANT
Stock grant
6,8206,820Mar 7, 2022Mar 23, 2023View →
CMMB
CHEMOMAB THERAPEUTICS LTD.
PURCHASEGRANT
Stock grant
6,8206,820Mar 7, 2022Mar 9, 2022View →
CMMB
CHEMOMAB THERAPEUTICS LTD.
PURCHASEGRANT
Stock grant
6,8206,820Mar 7, 2022Mar 15, 2022View →
CMMB
CHEMOMAB THERAPEUTICS LTD.
PURCHASEGRANT
Stock grant
6,8206,820Mar 7, 2022May 19, 2022View →
CMMB
CHEMOMAB THERAPEUTICS LTD.
PURCHASEGRANT
Stock grant
6,8206,820Mar 7, 2022Nov 18, 2022View →
CMMB
CHEMOMAB THERAPEUTICS LTD.
PURCHASE
2,000$7.43$14.9K4,409Dec 6, 2021Dec 8, 2021View →
CMMB
CHEMOMAB THERAPEUTICS LTD.
PURCHASEGRANT
Stock grant
11,88411,884Apr 19, 2021May 19, 2022View →
CMMB
CHEMOMAB THERAPEUTICS LTD.
PURCHASEGRANT
Stock grant
11,88411,884Apr 19, 2021Mar 23, 2023View →
CMMB
CHEMOMAB THERAPEUTICS LTD.
PURCHASEGRANT
Stock grant
11,88411,884Apr 19, 2021Mar 15, 2022View →
CMMB
CHEMOMAB THERAPEUTICS LTD.
PURCHASEGRANT
Stock grant
11,88411,884Apr 19, 2021Nov 18, 2022View →
CMMB
CHEMOMAB THERAPEUTICS LTD.
PURCHASEGRANT
Stock grant
11,88411,884Apr 19, 2021Apr 21, 2021View →
CMMB
CHEMOMAB THERAPEUTICS LTD.
PURCHASEGRANT
Stock grant
688688Mar 16, 2021Mar 23, 2023View →
CMMB
CHEMOMAB THERAPEUTICS LTD.
PURCHASEGRANT
Stock grant
688688Mar 16, 2021May 19, 2022View →
CMMB
CHEMOMAB THERAPEUTICS LTD.
PURCHASEGRANT
Stock grant
688688Mar 16, 2021Nov 18, 2022View →
CMMB
CHEMOMAB THERAPEUTICS LTD.
PURCHASE
2,409$41.51$100.0K2,409Mar 16, 2021Mar 26, 2021View →
CMMB
CHEMOMAB THERAPEUTICS LTD.
PURCHASEGRANT
Stock grant
688688Mar 16, 2021Mar 15, 2022View →
CMMB
CHEMOMAB THERAPEUTICS LTD.
PURCHASE
688688Mar 16, 2021Mar 26, 2021View →
Other insiders · CMMB
Loading peer insiders…
About this filer
CIK 0001840006
ROLE
Director
PRIMARY
CMMB
COMPANIES
1
ACTIVE SINCE
Mar 2021
MARKETPEEL · /INSIDER/0001840006DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback